Name | Number of supported studies | Average coverage | |
---|---|---|---|
natural killer cell | 6 studies | 18% ± 2% | |
CD16-positive, CD56-dim natural killer cell, human | 4 studies | 17% ± 2% | |
CD16-negative, CD56-bright natural killer cell, human | 3 studies | 17% ± 1% |
Insufficient scRNA-seq data for expression of HENMT1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 283.76 | 21 / 21 | 95% | 25.48 | 481 / 504 |
breast | 100% | 372.69 | 457 / 459 | 93% | 26.57 | 1043 / 1118 |
prostate | 98% | 236.05 | 239 / 245 | 95% | 12.94 | 478 / 502 |
uterus | 98% | 215.07 | 166 / 170 | 94% | 36.00 | 433 / 459 |
ovary | 98% | 314.70 | 177 / 180 | 93% | 17.35 | 402 / 430 |
intestine | 99% | 353.52 | 958 / 966 | 90% | 22.97 | 475 / 527 |
lung | 97% | 306.56 | 560 / 578 | 88% | 15.33 | 1022 / 1155 |
esophagus | 92% | 157.69 | 1336 / 1445 | 89% | 14.85 | 162 / 183 |
stomach | 88% | 152.45 | 315 / 359 | 90% | 20.00 | 256 / 286 |
skin | 96% | 251.57 | 1738 / 1809 | 81% | 15.88 | 382 / 472 |
thymus | 96% | 196.04 | 625 / 653 | 62% | 8.54 | 375 / 605 |
brain | 100% | 612.27 | 2631 / 2642 | 58% | 5.20 | 407 / 705 |
adrenal gland | 93% | 199.07 | 241 / 258 | 53% | 5.03 | 122 / 230 |
kidney | 79% | 149.42 | 70 / 89 | 47% | 3.54 | 421 / 901 |
pancreas | 30% | 34.98 | 97 / 328 | 94% | 18.05 | 167 / 178 |
lymph node | 0% | 0 | 0 / 0 | 100% | 30.79 | 29 / 29 |
spleen | 100% | 908.95 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 29.75 | 1 / 1 |
adipose | 99% | 305.39 | 1195 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 610.23 | 916 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 32.00 | 44 / 45 |
blood vessel | 93% | 188.07 | 1237 / 1335 | 0% | 0 | 0 / 0 |
muscle | 64% | 99.53 | 513 / 803 | 0% | 0 | 0 / 0 |
liver | 24% | 28.25 | 55 / 226 | 24% | 3.14 | 99 / 406 |
heart | 48% | 63.96 | 412 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 33% | 2.27 | 26 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0034587 | Biological process | piRNA processing |
GO_0001510 | Biological process | RNA methylation |
GO_0030422 | Biological process | siRNA processing |
GO_0043186 | Cellular component | P granule |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0008171 | Molecular function | O-methyltransferase activity |
GO_0008173 | Molecular function | RNA methyltransferase activity |
GO_0090486 | Molecular function | small RNA 2'-O-methyltransferase activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | HENMT1 |
Protein name | Small RNA 2'-O-methyltransferase (EC 2.1.1.386) (HEN1 methyltransferase homolog 1) |
Synonyms | C1orf59 |
Description | FUNCTION: Methyltransferase that adds a 2'-O-methyl group at the 3'-end of piRNAs, a class of 24 to 30 nucleotide RNAs that are generated by a Dicer-independent mechanism and are primarily derived from transposons and other repeated sequence elements. This probably protects the 3'-end of piRNAs from uridylation activity and subsequent degradation. Stabilization of piRNAs is essential for gametogenesis. . |
Accessions | A0A0A0MRN1 ENST00000370031.5 ENST00000651461.1 ENST00000420055.1 ENST00000370032.9 ENST00000402983.5 X6RGV9 Q5T8I9 |